Article

Analytical Evaluation of Whole Genome Sequencing for Acute Myeloid Leukemia

2025-10-31

Abstract excerpt

Acute myeloid leukemia (AML) is the most common leukemia in adults and current methods rely on cytogenic and molecular profiling for AML classification and risk stratification. Recent advances have demonstrated that next generation sequencing (NGS) may improve prognostic prediction and risk stratification of AML patients. A tumor-only high coverage (∼220x) whole genome sequencing (WGS) method was developed and its...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 77e95034-c216-569c-9109-a8e2e26b37f8
DOI: 10.1101/2025.10.30.25339095

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analytical Evaluation of Whole Genome Sequencing for Acute Myeloid LeukemiaDOI 10.1101/2025.10.30.25339095Read

Genomics of Acute Myeloid Leukemia at Diagnosis and RemissionSemantic proximity Read

Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future PerspectivesSemantic proximity Read

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasmsSemantic proximity Read

Advances in DNA/RNA Sequencing and Their Applications in Acute Myeloid Leukemia (AML)Semantic proximity Read

The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.Semantic proximity Read

The role of next-generation sequencing in acute myeloid leukemia.Semantic proximity Read

The role of next-generation sequencing in hematologic malignanciesSemantic proximity Read

Next Generation Sequencing of Acute Myeloid Leukemia: Influencing PrognosisSemantic proximity Read

Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AMLSemantic proximity Read

Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms.Semantic proximity Read

Design, implementation and clinical utility of next generation sequencing in myeloid malignancies: acute myeloid leukaemia and myelodysplastic syndrome.Semantic proximity Read

Clinical performance and utility of a comprehensive next-generation sequencing DNA panel for the simultaneous analysis of variants, TMB and MSI for myeloid neoplasms.Semantic proximity Read